Neonatal Blalock-Taussig Shunt: Technical Aspects and Postoperative Management

A systemic-pulmonary artery shunt in neonates with decreased pulmonary blood flow is technically demanding. We describe our surgical technique, postoperative management, and results in 19 neonates who underwent a modified Blalock-Taussig shunt between April 2003 and March 2006. Prostaglandin infusion was required in 8 patients who were critically cyanosed, and 5 were on inotropic support preoperatively. A 3.5 or 4.0-mm polytetrafluoroethylene graft was anastomosed with 8/0 polypropylene suture. Postoperatively, systemic pressure was kept slightly higher than normal, and heparin was started early. One patient required revision of the shunt, and one was reexplored for bleeding. There were 2 hospital deaths (mortality, 11%) in patients with preoperative hemodynamic instability. The mean follow-up period was 12 months, with no late postoperative shunt blockage or death. Meticulous surgical technique and judicious use of heparin and inotropic agents improved the outcome and reduced the incidence of shunt blockage and reexploration for bleeding.

[1]  M. Jeong,et al.  Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial. , 2008, Circulation Journal.

[2]  K. Sivakumar,et al.  Operative outcome and intermediate term follow-up of neonatal Blalock-Taussig shunts. , 2001, Indian heart journal.

[3]  A. Saxena,et al.  Modified Blalock-Taussig Shunt in Neonates: Determinants of Immediate Outcome , 2000 .

[4]  F. Lacour-Gayet,et al.  Systemic pulmonary shunts in neonates: early clinical outcome and choice of surgical approach. , 2000, The Annals of thoracic surgery.

[5]  M. A. Ali Khan,et al.  Results of 546 Blalock-Taussig shunts performed in 478 patients , 1998, Cardiology in the Young.

[6]  S. Qureshi,et al.  Effects of modified and classic Blalock-Taussig shunts on the pulmonary arterial tree. , 1998, The Annals of thoracic surgery.

[7]  J. Mullen,et al.  Modified Blalock-Taussig shunts: to heparinize or not to heparinize? , 1996, The Canadian journal of cardiology.

[8]  M. Marchand,et al.  [Systemic pulmonary shunts in the neonatal period. Short and medium-term results]. , 1995, Archives des maladies du coeur et des vaisseaux.

[9]  M. S. Snyder,et al.  A Five‐Year Clinical Experience with 112 Blalock‐Taussig Shunts , 1993, Journal of cardiac surgery.

[10]  P. Vouhé,et al.  Modified Blalock-Taussig shunts: results in infants less than 3 months of age. , 1990, The Annals of thoracic surgery.

[11]  B. Marino,et al.  Simultaneous patency of ductus arteriosus and surgical shunt in pulmonary atresia with intact ventricular septum. A cause of acute myocardial failure? , 1986, Scandinavian journal of thoracic and cardiovascular surgery.

[12]  J. Brenner,et al.  Classic versus modified Blalock-Taussig shunts in neonates and infants. , 1985, Circulation.

[13]  M. Ilbawi,et al.  Modified Blalock-Taussig shunt in newborn infants. , 1984, The Journal of thoracic and cardiovascular surgery.

[14]  J. Mack Surgical results and protocols in the spectrum of tetralogy of fallot: J. W. Kirklin, E. H. Blackstone, J. K. Kirklin, et al. Ann Surg 198:251–265, (September), 1983 , 1984 .

[15]  B. Perry,et al.  Classic shunting operations for congenital cyanotic heart defects. , 1982, The Journal of thoracic and cardiovascular surgery.

[16]  F. Macartney,et al.  Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. , 1981, The Journal of thoracic and cardiovascular surgery.